{
    "clinical_study": {
        "@rank": "159642", 
        "arm_group": {
            "arm_group_label": "Hypogonadotropic hypogonadism patients", 
            "description": "Treatment naive 25 patients with idiopathic hypogonadotrophic hypogonadism"
        }, 
        "brief_summary": {
            "textblock": "The aim of the present study was to demonstrate the RBP4 levels, association of RBP4 with\n      insulin resistance and influence of testosterone treatment on this cytokine in patients with\n      idiopathic hypogonadotropic hypogonadism."
        }, 
        "brief_title": "Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism", 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": "Idiopathic Hypogonadotropic Hypogonadism", 
        "condition_browse": {
            "mesh_term": "Hypogonadism"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        decreased serum testosterone concentration below the normal range (serum T < 300ng/dL),\n        FSH and LH levels within or below the normal range, absence of a pituitary or hypothalamic\n        mass lesions on MRI, presence of gonadotropin response to repetitive doses of GnRH, normal\n        smell test and normal karyotypes\n\n        Exclusion Criteria:\n\n        previous androgen treatment, history of smoking, presence of bilateral anorchia,\n        intellectual deficiency, diabetes mellitus, arterial hypertension or dyslipoproteinemia,\n        medication of any kind and drug abuse. Because of possible confounding effects, patients\n        with other hormone deficiencies were excluded.\n\n        -"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "26 Years", 
            "minimum_age": "19 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with hypogonadotrophic hypogonadism"
            }
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01758094", 
            "org_study_id": "24122012"
        }, 
        "intervention": {
            "arm_group_label": "Hypogonadotropic hypogonadism patients", 
            "description": "Drug used for treatment of hypogonadism", 
            "intervention_name": "Sustanon 250 mg ampule  (Testosterone esters)", 
            "intervention_type": "Drug", 
            "other_name": "No name"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Testosterone", 
                "Testosterone enanthate", 
                "Testosterone undecanoate", 
                "Testosterone 17 beta-cypionate", 
                "Methyltestosterone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hypogonadism", 
            "Retinol binding globulin 4", 
            "Testosterone treatment"
        ], 
        "lastchanged_date": "January 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06018"
                }, 
                "name": "Gulhane School of Medicine Dep. of Endocrinology and Metabolism"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "overall_official": {
            "affiliation": "Gulhane School of Medicine, Department of Endocrinology and Metabolism", 
            "last_name": "Aydogan Aydogdu, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Retinol binding protein 4, hs-CRP levels in patients with idiopathic hypogonadotrophic hypogonadism", 
            "safety_issue": "Yes", 
            "time_frame": "2008-2012"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01758094"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Gulhane School of Medicine", 
            "investigator_full_name": "Aydogan Aydogdu", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Effect of testosterone treatment on retinol binding globulin 4 and hs-CRP levels in patients with hypogodotrophic hypogonadism", 
            "safety_issue": "Yes", 
            "time_frame": "2008-2012"
        }, 
        "source": "Gulhane School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gulhane School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}